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and TNFa) were quantiﬁed in culture supernatants by ELISA. We observed
that the anti-ﬁbrotic factor HGF was not secreted by chondrocytes or ASC
alone but its secretion was induced after 7 days of co-culture.
Conclusions:We have set up optimal co-culture conditions for evaluating
the effect of ASC and MSC on the OA chondrocyte phenotype. The results
suggest that the main effect of ASC from abdominal subcutaneous fat
and MSC from OA donors is to maintain the chondrocyte phenotype by
reducing their dedifferentiation as observed by the decrease of ﬁbroblast-
associated markers. This effect is at least partly due to the induction of
HGF secretion which is a known anti-ﬁbrotic factor. Interestingly, this
anti-ﬁbrotic effect seems to depend on the cell origin and pathological
status.
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Purpose: Efforts to delay osteoarthritis through improving treatment
of damaged articular cartilage remains challenging. Sustained intra-
articular delivery of therapeutic agents that can promote cartilage repair
is of high potential clinical importance. Intra-articular injection of adeno-
associated virus (AAV) has been used in clinical trials for delivery of
bioactive substances. Methods to localize and control in vivo transgene
expression are important to enhancing the therapeutic efﬁciency and
safety of intra-articular gene therapy. This study tests the hypotheses
that (1) in vivo AAV transgene expression localizes to cartilage defects,
and that (2) in vivo transgene signal can be externally controlled using
oral doxycycline.
Methods: Longitudinal in vivo study was performed using twelve male
Sprague-Dawley rats with surgically created unilateral full thickness
cartilage injuries. To characterize the localization and persistence of
transgene expression, six rats received a single intra-articular injection
of AAV2-CMV-Luc one week after surgery to both injured and uninjured
stiﬂes. To characterize the controllability of the transgene expression, six
rats received a single injection of AAV2-tetracycline response element
(TRE)-Luc one week after surgery to both injured and uninjured stiﬂes.
Rats injected with the tetracycline controllable AAV2-TRE-Luc received
doxycycline in the drinking water beginning 14 days after AAV injection
for one week. Doxycycline was then removed from the drinking water.
Luciferase expression was evaluated over a 6-month period in both
groups of rats using the IVIS® Live Animal Imaging System (Xenogen). At
the time of sacriﬁce, stiﬂe joints were opened and luciferase expression
was evaluated to localize intra-articular transgene expression.
Results: Longitudinal evaluation of in vivo luciferase expression in
rats receiving AAV2-CMV-Luc using live animal imaging revealed
transgene expression from 7 days post-injection. Luciferase transgene
expression persisted and remained stable throughout the 6 months
study. When the joints were opened, luciferase expression was found
to be highly localized to the vicinity of the cartilage defect and
associated repair tissue. Rats that received the inducible AAV2-TRE-Luc
in the injured joint showed gene expression upregulation with addition
of doxycycline (p < 0.05) and downregulation of luciferase following
removal of doxycycline (p < 0.05) to the drinking water.
Conclusions: Longitudinal in vivo results showed persistent and stable
AAV2-mediated gene expression, which was localized to the vicinity
of the cartilage injury. Furthermore, this highly localized in vivo intra-
articular transgene expression was controllable by oral administration of
doxycycline. These data support further study of the in vivo therapeutic
potential of AAV for safe and localized delivery of bioactive substances
to improve cartilage repair following injury as a strategy to prevent or
delay the onset of osteoarthritis.
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Purpose: Articular cartilage has limited self-regeneration ability and,
once damaged leads to further cartilage degeneration and predisposes to
the development of osteoarthritis. It has been found that certain mouse
strains (MRL/MpJ, DBA/1) can regenerate their full-thickness articular
cartilage defects. These and another strain, LG/J, can also heal through-
and-through ear puncture wounds unlike C57BL/6 and SM/J strains.
MRL/MpJ and LG/J share 75% of their genome. It might indicate that
the healing ability in certain strains might be linked to their speciﬁc
genetic composition. To test this hypothesis, we developed a genetic
mouse model of articular cartilage regeneration and ear-wound healing
using recombinant inbred lines. These lines were generated from LG/J
(healer) and SM/J (non-healer) strains with each line containing unique
portions of the healing strain genome. We aim (i) to identify cartilage
regeneration and ear-wound healing phenotypes and (ii) to establish
the relationship between tissue regeneration (ear-wound healing) and
cartilage regeneration in these strains.
Methods: A total of nine recombinant inbred lines, parental and control
strains were used in this study. An acute full-thickness cartilage injury
was introduced through microsurgery in the trochlear groove of both
knees of 8-weeks old mice (n =350). Knee joints were harvested
at indicated time points. Parafﬁn embedded blocks were sagittally
sectioned and stained with toluidine blue. Slides were graded for ﬁve
parameters on a scale from 0 to 14 for cartilage regeneration. Selected
sections from each strain were stained for collagen types I and II. For
the ear-wound phenotype, a 2-mm through-and-through puncture was
made in mice (n =418) at 6-weeks of age and healing outcomes measured
after 4 weeks.
Results: Results showed that MRL/MpJ healed at 12 weeks while LG/J
and strain 6 showed healing trend only at 16 weeks (Fig. 1).
Fig. 1. Representative sagittal sections of cartilage repair phenotypes in
healer and non-healer strains.
All other recombinant inbred lines failed to regenerate cartilage at 12 or
16 weeks post-surgery. Similarly SM/J, C57BL/6 and surprisingly DBA/1
and DBA/2 strains did not heal (Fig. 2).
The neo-cartilage in healer strains (MRL/MpJ, LG/J and 6) showed type
II collagen (hyaline-like) and proteoglycan deposition. For ear-wound
healing, in addition to strains 6, MRL/MpJ and LG/J, strains 19, 35 and 46
also showed healing of ear wounds at 4 weeks (Fig. 3).
Conclusions: We conclude that cartilage regeneration is a strain
dependent phenomenon and is not always associated with ear-wound
healing. It is also tempting to speculate that a distinctive set of genes
might be involved in these processes. Overall, our study will allow us to
